8.695
price down icon1.86%   -0.165
 
loading
Schlusskurs vom Vortag:
$8.86
Offen:
$8.8
24-Stunden-Volumen:
10,642
Relative Volume:
0.09
Marktkapitalisierung:
$557.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-159.39M
KGV:
-
EPS:
-
Netto-Cashflow:
$-105.22M
1W Leistung:
-12.70%
1M Leistung:
-17.19%
6M Leistung:
-39.24%
1J Leistung:
-18.20%
1-Tages-Spanne:
Value
$8.67
$8.80
1-Wochen-Bereich:
Value
$8.67
$9.79
52-Wochen-Spanne:
Value
$8.67
$17.02

Abivax Adr Stock (ABVX) Company Profile

Name
Firmenname
Abivax Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
61
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-07
Name
Neueste SEC-Einreichungen
Name
ABVX's Discussions on Twitter

Vergleichen Sie ABVX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ABVX 8.695 557.45M 0 -159.39M -105.22M 0.00
VRTX 447.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.11 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.93 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.55 24.49B 3.30B -501.07M 1.03B 11.54

Abivax Adr Stock (ABVX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-14 Eingeleitet Leerink Partners Outperform
2023-11-14 Eingeleitet Morgan Stanley Equal-Weight

Abivax Adr Aktie (ABVX) Neueste Nachrichten

pulisher
Nov 19, 2024

Abivax Initiates $150 Million ATM Program on Nasdaq - TipRanks

Nov 19, 2024
pulisher
Nov 14, 2024

Abivax Reports Strong Q3 Financials and Clinical Progress - TipRanks

Nov 14, 2024
pulisher
Oct 15, 2024

Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 15, 2024
pulisher
Oct 15, 2024

Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex

Oct 15, 2024
pulisher
Oct 07, 2024

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.

Oct 07, 2024
pulisher
Sep 26, 2024

Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks

Sep 26, 2024
pulisher
Sep 25, 2024

Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks

Sep 25, 2024
pulisher
Sep 16, 2024

DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire

Sep 16, 2024
pulisher
Sep 14, 2024

Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN

Sep 14, 2024
pulisher
Sep 13, 2024

Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Sep 13, 2024
pulisher
Sep 09, 2024

Abivax SA Details Financial Struggles and Advances - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks

Sep 09, 2024
pulisher
Jul 15, 2024

Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.

Jul 15, 2024
pulisher
Jun 04, 2024

Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks

Jun 04, 2024
pulisher
May 07, 2024

Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks

May 07, 2024
pulisher
Apr 29, 2024

Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com

Apr 29, 2024
pulisher
Apr 02, 2024

Abivax SA Secures Funding and Expands Operations - TipRanks

Apr 02, 2024
pulisher
Oct 26, 2023

Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire

Oct 26, 2023

Finanzdaten der Abivax Adr-Aktie (ABVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):